XML 59 R23.htm IDEA: XBRL DOCUMENT v3.2.0.727
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)
 6 Months Ended
Jun. 30, 2015
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Changes In Carrying Amount Of Goodwill
Changes in the carrying amount of goodwill for the six months ended June 30, 2015 were as follows:
 
Specialty
Surgical
Solutions
 
Orthopedics and
Tissue Technologies
 
Spine
 
Total
 
(In thousands)
Goodwill, gross
$
281,829

 
$
81,650

 
$
409

 
$
363,888

Accumulated impairment losses
—

 
—

 
—

 
—

Goodwill at December 31, 2014
281,829

 
81,650

 
409

 
363,888

MicroFrance working capital and purchase price adjustments
(828
)
 
—

 
—

 
(828
)
Metasurg working capital and purchase price adjustment
—

 
263

 
—

 
263

Goodwill impairment charge
—

 
—

 
(409
)
 
(409
)
Foreign currency translation
(4,451
)
 
(1,441
)
 
—

 
(5,892
)
Balance, June 30, 2015
$
276,550

 
$
80,472

 
$
—

 
$
357,022
Components of Company's Identifiable Intangible Assets
The components of the Company’s identifiable intangible assets were as follows:
 
June 30, 2015
 
Weighted
Average
Life
 
Cost
 
Accumulated
Amortization
 
Net
 
(Dollars in thousands)
Completed technology
18 years
 
$
344,406

 
$
(72,393
)
 
$
272,013

Customer relationships
12 years
 
159,548

 
(91,621
)
 
67,927

Trademarks/brand names
34 years
 
43,221

 
(15,814
)
 
27,407

Trademarks/brand names
Indefinite
 
48,484

 
—

 
48,484

Supplier relationships
27 years
 
34,721

 
(11,522
)
 
23,199

All other (1)
4 years
 
2,721

 
(1,168
)
 
1,553

 
 
 
$
633,101

 
$
(192,518
)
 
$
440,583


 
December 31, 2014
 
Weighted
Average
Life
 
Cost
 
Accumulated
Amortization
 
Net
 
(Dollars in thousands)
Completed technology
18 years
 
$
345,082

 
$
(62,920
)
 
$
282,162

Customer relationships
12 years
 
162,031

 
(87,653
)
 
74,378

Trademarks/brand names
34 years
 
44,520

 
(15,755
)
 
28,765

Trademarks/brand names
Indefinite
 
48,484

 
—

 
48,484

Supplier relationships
27 years
 
34,721

 
(10,809
)
 
23,912

All other (1)
4 years
 
4,810

 
(3,052
)
 
1,758

 
 
 
$
639,648

 
$
(180,189
)
 
$
459,459


 
(1) 
At June 30, 2015 and December 31, 2014, all other included in-process research and development ("IPR&D") of $1.4 million in both periods, which was indefinite-lived.